These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

319 related items for PubMed ID: 31441020

  • 1. Stathmin 1 is highly expressed and associated with survival outcome in malignant adrenocortical tumours.
    Dos Santos Passaia B, Lima K, Kremer JL, da Conceição BB, de Paula Mariani BM, da Silva JCL, Zerbini MCN, Fragoso MCBV, Machado-Neto JA, Lotfi CFP.
    Invest New Drugs; 2020 Jun; 38(3):899-908. PubMed ID: 31441020
    [Abstract] [Full Text] [Related]

  • 2. STMN1 is Overexpressed in Adrenocortical Carcinoma and Promotes a More Aggressive Phenotype In Vitro.
    Aronova A, Min IM, Crowley MJP, Panjwani SJ, Finnerty BM, Scognamiglio T, Liu YF, Whitsett TG, Garg S, Demeure MJ, Elemento O, Zarnegar R, Fahey TJ.
    Ann Surg Oncol; 2018 Mar; 25(3):792-800. PubMed ID: 29214451
    [Abstract] [Full Text] [Related]

  • 3. Overexpression of Stathmin 1 correlates with poor prognosis and promotes cell migration and proliferation in oesophageal squamous cell carcinoma.
    Ni PZ, He JZ, Wu ZY, Ji X, Chen LQ, Xu XE, Liao LD, Wu JY, Li EM, Xu LY.
    Oncol Rep; 2017 Dec; 38(6):3608-3618. PubMed ID: 29039594
    [Abstract] [Full Text] [Related]

  • 4. Targeted Assessment of G0S2 Methylation Identifies a Rapidly Recurrent, Routinely Fatal Molecular Subtype of Adrenocortical Carcinoma.
    Mohan DR, Lerario AM, Else T, Mukherjee B, Almeida MQ, Vinco M, Rege J, Mariani BMP, Zerbini MCN, Mendonca BB, Latronico AC, Marie SKN, Rainey WE, Giordano TJ, Fragoso MCBV, Hammer GD.
    Clin Cancer Res; 2019 Jun 01; 25(11):3276-3288. PubMed ID: 30770352
    [Abstract] [Full Text] [Related]

  • 5. Preclinical assessment of synergistic efficacy of MELK and CDK inhibitors in adrenocortical cancer.
    Laha D, Grant RRC, Mishra P, Boufraqech M, Shen M, Zhang YQ, Hall MD, Quezado M, De Melo MS, Del Rivero J, Zeiger M, Nilubol N.
    J Exp Clin Cancer Res; 2022 Sep 23; 41(1):282. PubMed ID: 36151566
    [Abstract] [Full Text] [Related]

  • 6. Expression patterns and prognostic value of m6A RNA methylation regulators in adrenocortical carcinoma.
    Fu Y, Sun S, Bi J, Kong C, Yin L.
    Medicine (Baltimore); 2021 Mar 12; 100(10):e25031. PubMed ID: 33725886
    [Abstract] [Full Text] [Related]

  • 7. Bioinformatic analyses and experimental validation of the role of m6A RNA methylation regulators in progression and prognosis of adrenocortical carcinoma.
    Xu F, Guan Y, Ma Y, Xue L, Zhang P, Yang X, Chong T.
    Aging (Albany NY); 2021 Apr 21; 13(8):11919-11941. PubMed ID: 33952721
    [Abstract] [Full Text] [Related]

  • 8. Expression profiles analysis identifies the values of carcinogenesis and the prognostic prediction of three genes in adrenocortical carcinoma.
    Gao Z, Man X, Li Z, Bi J, Liu X, Li Z, Zhu Y, Zhang Z, Kong C.
    Oncol Rep; 2019 Apr 21; 41(4):2440-2452. PubMed ID: 30816525
    [Abstract] [Full Text] [Related]

  • 9. Identification of prognostic genes in adrenocortical carcinoma microenvironment based on bioinformatic methods.
    Li X, Gao Y, Xu Z, Zhang Z, Zheng Y, Qi F.
    Cancer Med; 2020 Feb 21; 9(3):1161-1172. PubMed ID: 31856409
    [Abstract] [Full Text] [Related]

  • 10. High STMN1 Expression is Associated with Cancer Progression and Chemo-Resistance in Lung Squamous Cell Carcinoma.
    Bao P, Yokobori T, Altan B, Iijima M, Azuma Y, Onozato R, Yajima T, Watanabe A, Mogi A, Shimizu K, Nagashima T, Ohtaki Y, Obayashi K, Nakazawa S, Bai T, Kawabata-Iwakawa R, Asao T, Kaira K, Nishiyama M, Kuwano H.
    Ann Surg Oncol; 2017 Dec 21; 24(13):4017-4024. PubMed ID: 28933054
    [Abstract] [Full Text] [Related]

  • 11. Epigenetic silencing of RASSF1A deregulates cytoskeleton and promotes malignant behavior of adrenocortical carcinoma.
    Korah R, Healy JM, Kunstman JW, Fonseca AL, Ameri AH, Prasad ML, Carling T.
    Mol Cancer; 2013 Aug 05; 12():87. PubMed ID: 23915220
    [Abstract] [Full Text] [Related]

  • 12. Identification of NDRG Family Member 4 (NDRG4) and CDC28 Protein Kinase Regulatory Subunit 2 (CKS2) as Key Prognostic Genes in Adrenocortical Carcinoma by Transcriptomic Analysis.
    Yang Z, Cheng H, Zhang Y, Zhou Y.
    Med Sci Monit; 2021 Mar 05; 27():e928523. PubMed ID: 33667214
    [Abstract] [Full Text] [Related]

  • 13. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
    Buishand FO, Liu-Chittenden Y, Fan Y, Tirosh A, Gara SK, Patel D, Meerzaman D, Kebebew E.
    Surgery; 2020 Jan 05; 167(1):224-232. PubMed ID: 31522749
    [Abstract] [Full Text] [Related]

  • 14. Identification of survival-associated alternative splicing events and signatures in adrenocortical carcinoma based on TCGA SpliceSeq data.
    Xu N, Ke ZB, Lin XD, Lin F, Chen SH, Wu YP, Chen YH, Wei Y, Zheng QS.
    Aging (Albany NY); 2020 Mar 26; 12(6):4996-5009. PubMed ID: 32217810
    [Abstract] [Full Text] [Related]

  • 15. Comprehensive genomic analysis of adrenocortical carcinoma reveals genetic profiles associated with patient survival.
    Sun-Zhang A, Juhlin CC, Carling T, Scholl U, Schott M, Larsson C, Bajalica-Lagercrantz S.
    ESMO Open; 2024 Jul 26; 9(7):103617. PubMed ID: 38935991
    [Abstract] [Full Text] [Related]

  • 16. Targeted Molecular Analysis in Adrenocortical Carcinomas: A Strategy Toward Improved Personalized Prognostication.
    Lippert J, Appenzeller S, Liang R, Sbiera S, Kircher S, Altieri B, Nanda I, Weigand I, Gehrig A, Steinhauer S, Riemens RJM, Rosenwald A, Müller CR, Kroiss M, Rost S, Fassnacht M, Ronchi CL.
    J Clin Endocrinol Metab; 2018 Dec 01; 103(12):4511-4523. PubMed ID: 30113656
    [Abstract] [Full Text] [Related]

  • 17. Identification of prognostic metabolic genes in adrenocortical carcinoma and establishment of a prognostic nomogram: A bioinformatic study.
    Chen Q, Ren Z, Liu D, Jin Z, Wang X, Zhang R, Liu Q, Cheng W.
    Medicine (Baltimore); 2021 Dec 17; 100(50):e27864. PubMed ID: 34918636
    [Abstract] [Full Text] [Related]

  • 18. LncRNA HOTAIR participates in the development and progression of adrenocortical carcinoma via regulating cell cycle.
    Yan ZC, He L, Qiu JH, Deng WT, Lu JR, Yuan Z, Liu DJ, Zheng RQ, Jiang W.
    Eur Rev Med Pharmacol Sci; 2018 Oct 17; 22(20):6640-6649. PubMed ID: 30402836
    [Abstract] [Full Text] [Related]

  • 19. Stathmin 1 is a potential novel oncogene in melanoma.
    Chen J, Abi-Daoud M, Wang A, Yang X, Zhang X, Feilotter HE, Tron VA.
    Oncogene; 2013 Mar 07; 32(10):1330-7. PubMed ID: 22665054
    [Abstract] [Full Text] [Related]

  • 20. Anti-STMN1 therapy improves sensitivity to antimicrotubule drugs in esophageal squamous cell carcinoma.
    Wang S, Akhtar J, Wang Z.
    Tumour Biol; 2015 Sep 07; 36(10):7797-806. PubMed ID: 25944168
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.